Abstract
A controlled drug delivery system which provides stable plasma concentration could be the most appropriate dosage form for the successful delivery of selegiline. The objective of this study was to develop nanospheres of selegiline using gelatin and evaluate in vitro for the feasibility of oral delivery. Nanospheres of selegiline were prepared by spray drying method and evaluated for compatibility, particle size, surface morphology and in vitro drug release. Compatibility studies indicate no interaction between selegiline and gelatin. Moderate production recovery (89.52 ± 3.71%) and high drug content (98.41± 1.22%) were observed for the prepared formulation. Scanning electron microscopy images indicate that the prepared nanospheres possess round external smooth surface with a continuous wall, although they were shriveled. In vitro drug release profile suggests two phase drug release, an initial burst release followed by a slow release over an extended period of time (~10 h). The release kinetics indicates higher regression coefficient values (R2= 0.9641) with Korsmeyer-Peppas fit, suggesting that the release of the drug primarily governed by Fick’s law of diffusion. The in vitro data provided above indicate that the newly developed gelatin nanospheres have the desired characteristics for the controlled delivery of selegiline by oral route, which necessitate further in vivo studies.
Keywords: Selegiline, nanospheres, gelatin, in vitro, release kinetics
Current Nanoscience
Title:Formulation and In Vitro Evaluation of Gelatin Nanospheres for the Oral Delivery of Selegiline
Volume: 9 Issue: 1
Author(s): Bandar E. Al-Dhubiab
Affiliation:
Keywords: Selegiline, nanospheres, gelatin, in vitro, release kinetics
Abstract: A controlled drug delivery system which provides stable plasma concentration could be the most appropriate dosage form for the successful delivery of selegiline. The objective of this study was to develop nanospheres of selegiline using gelatin and evaluate in vitro for the feasibility of oral delivery. Nanospheres of selegiline were prepared by spray drying method and evaluated for compatibility, particle size, surface morphology and in vitro drug release. Compatibility studies indicate no interaction between selegiline and gelatin. Moderate production recovery (89.52 ± 3.71%) and high drug content (98.41± 1.22%) were observed for the prepared formulation. Scanning electron microscopy images indicate that the prepared nanospheres possess round external smooth surface with a continuous wall, although they were shriveled. In vitro drug release profile suggests two phase drug release, an initial burst release followed by a slow release over an extended period of time (~10 h). The release kinetics indicates higher regression coefficient values (R2= 0.9641) with Korsmeyer-Peppas fit, suggesting that the release of the drug primarily governed by Fick’s law of diffusion. The in vitro data provided above indicate that the newly developed gelatin nanospheres have the desired characteristics for the controlled delivery of selegiline by oral route, which necessitate further in vivo studies.
Export Options
About this article
Cite this article as:
E. Al-Dhubiab Bandar, Formulation and In Vitro Evaluation of Gelatin Nanospheres for the Oral Delivery of Selegiline, Current Nanoscience 2013; 9 (1) . https://dx.doi.org/10.2174/1573413711309010006
DOI https://dx.doi.org/10.2174/1573413711309010006 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry Stem Cell Patents: An Innovative Approach to Anti-Cancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery Evaluation of Anticancer, Antibacterial and Antioxidant Properties of a Medicinally Treasured Fern Tectaria coadunata with its Phytoconstituents Analysis by HR-LCMS
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Applications of Crocus sativus L. (Saffron): A Review
The Natural Products Journal The use of Azoles Containing Natural Products in Cancer Prevention and Treatment: An Overview
Anti-Cancer Agents in Medicinal Chemistry Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment
Current Drug Metabolism Nanomedical Platform for Drug Delivery in Cancer
Current Organic Chemistry Pharmacologic Evidence of Green Tea in Targeting Tyrosine Kinases
Current Reviews in Clinical and Experimental Pharmacology Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy The mAP-KL Algorithm Combined with Mutual Information Network Used to Screen Hub Genes in Osteosarcoma
Current Bioinformatics Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Current Cancer Drug Targets Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) The Emerging Role of Exosomal Non-coding RNAs in Musculoskeletal Diseases
Current Pharmaceutical Design Self-Assembled Micelles of Amphiphilic PEGylated Drugs for Cancer Treatment
Current Drug Targets Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer
Recent Patents on Anti-Cancer Drug Discovery Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Current Gene Therapy